Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 2Other neoplasm 2Other hematologic neoplasm 2Myeloid 2Lymphoid 2Sarcoma 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Lymphoma, Follicular 28Lymphoma, B-Cell, Marginal Zone 28Leukemia, Lymphocytic, Chronic, B-Cell 28Lymphoma, Non-Hodgkin 27Lymphoma, Mantle-Cell 26Lymphoma, Large B-Cell, Diffuse 26Sezary Syndrome 25Mycosis Fungoides 25Leukemia, Myeloid, Acute 25Hodgkin Disease 25Multiple Myeloma 24Lymphoma, Large-Cell, Immunoblastic 24Congenital Abnormalities 24Burkitt Lymphoma 24Leukemia, Myeloid, Chronic-Phase 20Leukemia, Myeloid, Accelerated Phase 20Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma, Extranodal NK-T-Cell 19Myeloproliferative Disorders 18Lymphoma, Large-Cell, Anaplastic 18Waldenstrom Macroglobulinemia 17Recurrence 16Leukemia, Myelomonocytic, Chronic 16Immunoblastic Lymphadenopathy 16Dendritic Cell Sarcoma, Interdigitating 16Lymphoma 15Leukemia, Hairy Cell 15Leukemia 15

Interventions

Peripheral Blood Stem Cell Transplantation 3Epoetin Alfa 3Darbepoetin alfa 3Cyclophosphamide 3liposomal amphotericin B 2fludarabine phosphate 2Morphine 2Methylprednisolone 2Filgrastim 2Fentanyl 2Cyclosporine 2Caspofungin 2Antilymphocyte Serum 2pyroxamide 1ferrous sulfate 1ferric gluconate 1Whole-Body Irradiation 1Watchful Waiting 1Therapeutics 1Tetradecanoylphorbol Acetate 1Tacrolimus 1Sucrose 1Radiotherapy 1Prednisone 1Phenytoin 1Pemetrexed 1Oxycodone 1Ondansetron 1Mycophenolic Acid 1Music Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Monoclonal Gammopathy of Undetermined Significance × Mycophenolic Acid × Dermatologic × Clear all
NCT00245037 2017-09-27

Bu Flu TBI

OHSU Knight Cancer Institute

Phase 1/2 Completed
147 enrolled 19 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡